Start:
April 3, 2018
End:
October 31, 2020
Enrollment:
40
This study will explore the use of transcranial magnetic stimulation (TMS) integrated with functional magnetic resonance imaging (fMRI) for diagnosing preclinical dementia and support development of a more sensitive diagnostic tool for dementia. TMS is a noninvasive approach to stimulate the brain. fMRI, which measures the brain's functional connectivity patterns, will be conducted when the brain is in a resting state, before and after the TMS procedure. Participants will undergo the TMS and fMRI procedures in a single day visit.
Minimum Age: 60 Years
Maximum Age: 75 Years
Participants with mild cognitive impairment:
Healthy participants will be screened with the MMSE.
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: University of Arizona
Source: ClinicalTrials.gov ID: NCT03652012
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health